Abstract
Current knowledge about functional connectivity in obsessive-compulsive disorder (OCD) is based on small-scale studies, limiting the generalizability of results. Moreover, the majority of studies have focused only on predefined regions or functional networks rather than connectivity throughout the entire brain. Here, we investigated differences in resting-state functional connectivity between OCD patients and healthy controls (HC) using mega-analysis of data from 1024 OCD patients and 1028 HC from 28 independent samples of the ENIGMA-OCD consortium. We assessed group differences in whole-brain functional connectivity at both the regional and network level, and investigated whether functional connectivity could serve as biomarker to identify patient status at the individual level using machine learning analysis. The mega-analyses revealed widespread abnormalities in functional connectivity in OCD, with global hypo-connectivity (Cohen’s d: -0.27 to -0.13) and few hyper-connections, mainly with the thalamus (Cohen’s d: 0.19 to 0.22). Most hypo-connections were located within the sensorimotor network and no fronto-striatal abnormalities were found. Overall, classification performances were poor, with area-under-the-receiver-operating-characteristic curve (AUC) scores ranging between 0.567 and 0.673, with better classification for medicated (AUC = 0.702) than unmedicated (AUC = 0.608) patients versus healthy controls. These findings provide partial support for existing pathophysiological models of OCD and highlight the important role of the sensorimotor network in OCD. However, resting-state connectivity does not so far provide an accurate biomarker for identifying patients at the individual level.
Original language | English |
---|---|
Pages (from-to) | 4307-4319 |
Number of pages | 13 |
Journal | Molecular Psychiatry |
Volume | 28 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2023 |
Externally published | Yes |
Funding
Funders | Funder number |
---|---|
Agència de Gestió d'Ajuts Universitaris i de Recerca | |
South African Medical Research Council | |
Spanish Ministry of Universities | |
Fondo de Investigaciones Sanitarias | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
Michael Smith Health Research BC | |
Biogen | |
Heidehof Stiftung | |
Ministero della Salute | |
Obsessive-Compulsive Foundation | |
Government of India | |
Brain and Behavior Research Foundation | |
National Alliance for Research on Schizophrenia and Depression | |
National Research Foundation | |
European Regional Development Fund | |
International OCD Foundation | |
Japan Agency for Medical Research and Development | JP22dm0307002, JP22dm0307008 |
National Natural Science Foundation of China | 81871057, 82171495, 82071518 |
Clinical and Public Health Research Center | IA/CRC/19/1/610005 |
National Institute on Aging Research Project | R01AG058854 |
Japan Society for the Promotion of Science | 21K07547, 22K15766, 19K03309, 18K15523, 22H01090, 16K04344, 21K03084, 22K07598 |
Department of Science and Technology, Ministry of Science and Technology, India | IFA12-LSBM-26, SR/S0/HS/0016/2011 |
AUGUR | 2017SGR 1247 |
Netherlands Brain Foundation | 2010(1 |
Instituto de Salud Carlos III | CM21/00278, PI18/00856 |
Helse Vest Health Authority | 911754, 911880 |
Fundació la Marató de TV3 | 091810 |
Department of Biotechnology, Ministry of Science and Technology, India | BT/ PR13334/Med/30/259/2009, BT/06/IYBA/2012 |
European Commission | MAZ/2021/11 |
Hartmann Müller-Stiftung für Medizinische Forschung | 1460 |
IRCCS Fondazione Santa Lucia | RC19-20-21-22/A |
Deutsche Forschungsgemeinschaft | VE 892/2-1, KO 3744/11-1 |
Conselho Nacional de Desenvolvimento Científico e Tecnológico | 303754/2018-4 |
Consejería de Salud y Familias, Junta de Andalucía | PI11/01419 |
Key Technologies Research and Development Program | 2022YFE0103700 |
National Institute of Neurological Disorders and Stroke | RO1NS107513 |
Fundação para a Ciência e a Tecnologia | UIDP/50026/2020, UIDB/50026/2020, NORTE-01-0145-FEDER-000023, NORTE-01-0145-FEDER-000013, 2020.07946 |
Amsterdam Neuroscience | CIA-2019-03-A |
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | 320030_130237 |
European Social Fund | FI17/00294, PI19/01171 |
Else Kröner-Fresenius-Stiftung | 2017_A101 |
ZonMw | 016.156.318, 165.610.002, 916.86.038, 917.15.318 |
National Institute of Mental Health | R01MH121520, R01MH104648, R01MH116147, K24MH121571, R01MH117601, R21MH093889, R01MH085900, R21MH101441, R01MH111794, R01AG059874, R33MH107589, P41EB015922, 5R01MH116038, R01MH081864, R01MH126981, R01MH123163, K23 MH115206, R01MH121246, R01MH126213 |
The Wellcome Trust DBT India Alliance | IA/CPHE/18/1/503956, 500236/Z/11/Z |
National Institutes of Health | U54 EB020403 |